< Back to previous page



The present invention relates to compounds of formula (A) as defined herein having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to pharmaceutical 5 compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the 10 administration of a therapeutical amount of such compounds, optionally combined with one or more other drugs having antiviral activity.
Patent Publication Number: EP2516008
Source: EPO
Year filing: 2010
Year approval: 2014
Year publication: 2014
Status: Assigned
Technology domains: Pharmaceuticals
Validated for IOF-key: Yes
Attributed to: Associatie KULeuven